Patrick Daly
Publishes 1 feed
SOHO Insider
10 posts · contributor
Lately
Partnership expands access to CLL treatment in low-, middle-income countries
Phase 1 data reported for anti-CD123 CAR T-cell therapy in relapsed or refractory AML, BPDCN
Drs. George Lenz and Loretta Nastoupil discuss phase 3 FRONTMIND study
FDA grants accelerated approval to iberdomide combo in multiple myeloma
Post-transplantation outcomes have improved for Hodgkin lymphoma
Fedratinib demonstrates favorable OS in MDS/MPN overlap syndrome
NICE recommends acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukemia
FDA approves subcutaneous isatuximab-irfc for multiple myeloma
ASCO and EHA 2026 updates on the third-gen TKI olverembatinib
Global KMT2A MRD testing launched for AML,ALL
Everything on this page was read from markup Patrick Daly published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON